慢性粒细胞白血病治疗进展及存在的临床问题
Advances and clinical problems in treatment of chronic myeloid leukemia
出处
《福建医科大学学报》
2004年第2期231-232,共2页
Journal of Fujian Medical University
参考文献11
-
1Shtivelman E,Lifshitz B,Gale RP,et al.Fused transcript of abl and bcr genes in chronic myelogeneous leukemia[J].Nature,1985,315(6020):550-554.
-
2Druker BJ,Talpaz M,Resta DJ,et al.Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia[J].N Eng J Med,2001,344(14):1031-1037.
-
3Savage DG,Antman KH.Imatinib mesylate--a new oral targeted therapy[J].N Engl J Med,2002,346(9):683-693.
-
4Talpaz M,Silver RT,Druker BJ,et al.Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia:results of phase 2 study[J].Blood,2002,99(6):1928-1937.
-
5Kantarjian H,Sawyers C,Hochhaus A,et al.Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia[J].New Engl J Med,2002,346(9):645-652.
-
6O'Brien SG,Guilhot F,Larson RA,et al.Imatinib compared with interferon and low dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia[J].N Eng J Med,2003,348(11):994-1004.
-
7Azam M,Latek RR,Daley GQ.Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL[J].Cell,2003,112(6):831-843.
-
8Van Rhee F,Szydlo RM,Hermans J,et al.Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase:a report from the chronic leukemia working party of the European group for blood and marrow transplantation[J].Bone Marrow Transplant,1997,20(7):553-560.
-
9Or R,Shapira MY,Resnick I,et al.Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase[J].Blood,2003,101(2):441-445.
-
10Goldman JM,Druker BJ.Chronic myeloid leukemia:current treatment options[J].Blood,2001,98(7):2039-2042.
-
1王艳芳,苏丽萍,周永安.bcr—abl基因真核表达载体的构建及其在COS-7细胞中的表达[J].白血病.淋巴瘤,2010,19(10):596-599.
-
2单学赟,陈宝安,夏国华,许文林,丁家华,高冲,孙耘玉,王骏,程坚,赵刚,鲍文,宋慧慧,高峰,王飞,王雪梅.酪氨酸激酶抑制剂逆转K562/A02细胞多药耐药的研究[J].中国实验血液学杂志,2010,18(1):90-95. 被引量:3
-
3王耀平.费城染色体阳性急性淋巴细胞白血病治疗进展[J].实用医院临床杂志,2008,5(3):21-23. 被引量:2
-
4孟凡凯,孙汉英,李春蕊,刘文励,周剑峰.c-Ets1对K562细胞BCR-ABL融合基因表达的影响[J].华中科技大学学报(医学版),2011,40(5):550-552.
-
5姚利.RT-PCR检测BCR-ABL基因中的几个问题[J].国外医学(临床生物化学与检验学分册),2000,21(4):208-208.
-
6李红玲.慢性粒细胞白血病bcr-abl及p53基因突变检测及临床意义[J].中华内科杂志,2001,40(11):752-752.
-
7李红玲,郭湘云,任守义,刘静,沈世林.慢性粒细胞性白血病患者bcr-abl基因、P53基因动态监测的临床意义[J].甘肃科技,2001,17(1):40-40.
-
8谢飞.微RNA,癌症诊断的新纪元[J].小学科学(学生版),2015(7):14-16.
-
9郑永昌,杜顺达,赵海涛,卢欣,毛一雷,桑新亭.胆囊癌并发类白血病反应及高钙血症1例并文献复习[J].癌症进展,2016,14(1):90-91. 被引量:2
-
10何成年,刘晓民,滑红英.巨脾并多发性脾动脉瘤一例[J].中华放射学杂志,2009,43(3):325-325.